Henri Bounameaux Explained

Henri Bounameaux is a known clinical faculty and Professor of Medicine (hon), specialized in internal and vascular medicine (angiology), and general medicine.[1]

Professor Bounameaux served as the Dean of Faculty of medicine at the University of Geneva, Switzerland. Presently, Professor Bounameaux is a distinguished professor of the University of Geneva and the President of the Swiss Academy of Medical Sciences (SAMS).[2]

Professor Bounameaux has authored numerous research papers and several review papers. His research interests cover all aspects related to the prevention, diagnosis, and treatment of venous thromboembolism.[3] His main contribution to the field relates to the non-invasive work-up of suspected pulmonary embolism, particularly the use of fibrin D-dimer. He was among the first scientists in the late eighties to suggest that this dosage in the patient plasma allowed to safely rule out venous thromboembolism, which was demonstrated in subsequent publications of the Geneva research group.[4] [5] He was among the first scientists in the late eighties to suggest that this dosage in the patient plasma allowed to safely rule out venous thromboembolism, which was demonstrated in the subsequent publications of the Geneva research group.[6]

Early life and education

Henri Bounameaux completed his primary and secondary education at Lubumbashi (Belgian Congo, Zaïre) and Baccalaureate type C from St.-Louis, France in 1971.[7]

He received his medical degree and post-graduate specialization from the Faculty of medicine, University of Basel, and is board-certified in internal and vascular medicine (angiology). He completed the post-doctoral education from Center for Thrombosis and Vascular Research, Belgium.[8]

He is now an emeritus professor of the University of Geneva.

Research

Professor Bounameaux research interests are broad and include studies on Non-invasive vascular diagnosis, venous thromboembolism and pulmonary embolism & Cardiology, Angiology, Hemostasis.[3] [9] His main contribution to the field relates to the non-invasive work-up of suspected pulmonary embolism, particularly the use of fibrin D-dimer. He was among the first scientists in the late eighties to suggest that this dosage in the patient plasma allowed to safely rule out venous thromboembolism, which was demonstrated in subsequent publications of the Geneva research group.[10]

Awards

During his career, Professor Bounameaux has received the following awards and honors:

Publications

External links

Notes and References

  1. Web site: Professor Henri Bounameaux. 2020-12-28. GARFIELD-VTE Registry. en-GB.
  2. Web site: Executive Board. 2020-12-28. Executive Board. en-GB.
  3. Bounameaux. Henri. Perrier. Arnaud. Righini. Marc. 2010-10-06. Diagnosis of venous thromboembolism: an update. Vascular Medicine. 15. 5. 399–406. en. 10.1177/1358863X10378788. 20926499.
  4. Righini. M.. Perrier. A.. De Moerloose. P.. Bounameaux. H.. July 2008. D-Dimer for venous thromboembolism diagnosis: 20 years later. Journal of Thrombosis and Haemostasis. 6. 7. 1059–1071. 10.1111/j.1538-7836.2008.02981.x. 1538-7836. 18419743.
  5. Perrier. Arnaud. Desmarais. Sylvie. Goehring. Catherine. de MOERLOOSE. Philippe. Morabia. Alfredo. Unger. Pierre-François. Slosman. Daniel. Junod. Alain. Bounameaux. Henri. D-dimer Testing for Suspected Pulmonary Embolism in Outpatients. American Journal of Respiratory and Critical Care Medicine. 1997. en. 156. 2. 492–496. 10.1164/ajrccm.156.2.9702032. 9279229. 1073-449X.
  6. Perrier. A.. Bounameaux. H.. Cost-effective diagnosis of deep vein thrombosis and pulmonary embolism. Thrombosis and Haemostasis. 2001. 86. 1. 475–487. 10.1055/s-0037-1616245. 0340-6245. 11487038. 21227162 .
  7. Web site: 2019-06-30. Meet Our First Titan of Thrombosis: Professor Henri Bounameaux. 2020-12-28. North American Thrombosis Forum. en-US.
  8. Web site: jeantet.
  9. Bounameaux. Henri. Haas. Sylvia. Farjat. Alfredo E.. Ageno. Walter. Weitz. Jeffrey I.. Goldhaber. Samuel Z.. Turpie. Alexander G.G.. Goto. Shinya. Angchaisuksiri. Pantep. Nielsen. Joern Dalsgaard. Kayani. Gloria. July 2020. Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE. Thrombosis Research. 191. 103–112. 10.1016/j.thromres.2020.04.036. 32422442. 218689822 . 0049-3848.
  10. Righini. M.. Perrier. A.. De Moerloose. P.. Bounameaux. H.. 2008-07-02. D-Dimer for venous thromboembolism diagnosis: 20 years later. Journal of Thrombosis and Haemostasis. 6. 7. 1059–1071. 10.1111/j.1538-7836.2008.02981.x. 1538-7836. 18419743.
  11. Web site: BIOGRAPHY. 2020-12-28. www.tri-ist.com.
  12. Web site: unige.ch.
  13. Bounameaux. H.. Cirafici. P.. de Moerloose. P.. Schneider. P. A.. Slosman. D.. Reber. G.. Unger. P. F.. 1991-01-26. Measurement of D-dimer in plasma as diagnostic aid in suspected pulmonary embolism. Lancet. 337. 8735. 196–200. 10.1016/0140-6736(91)92158-x. 0140-6736. 1670841. 40311333.
  14. The EINSTEIN–PE Investigators. 2012-04-05. Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism. New England Journal of Medicine. en. 366. 14. 1287–1297. 10.1056/NEJMoa1113572. 22449293. 0028-4793. free.